High RAD51 mRNA expression characterize estrogen receptor-positive/ progesteron receptor-negative breast cancer and is associated with patient's outcome

Raffaela Barbano, Massimiliano Copetti, Giuseppe Perrone, Valerio Pazienza, Lucia Anna Muscarella, Teresa Balsamo, Clelia Tiziana Storlazzi, Maria Ripoli, Monica Rinaldi, Vanna Maria Valori, Tiziana Pia Latiano, Evaristo Maiello, Pietro Stanziale, Massimo Carella, Alessandra Mangia, Fabio Pellegrini, Michele Bisceglia, Andrea Onetti Muda, Vittorio Altomare, Roberto MurgoVito Michele Fazio, Paola Parrella

Research output: Contribution to journalArticlepeer-review

Abstract

Mutations in DNA double-strand breaks (DSB) repair genes are involved in the pathogenesis of hereditary mammary tumors, it is, however, still unclear whether defects in this pathway may play a role in sporadic breast cancer. In this study, we initially determined mRNA expression of 15 DSB related genes by reverse transcription quantitative polymerase chain reaction in paired normal tissue and cancer specimen from 20 breast cancer cases to classify them into homogeneous clusters. G22P1/ku70, ATR and RAD51 genes were differentially expressed in the three branches recognized by clustering analysis. In particular, a breast cancer subgroup characterized by high RAD51 mRNA levels and estrogen receptor (ER)-positive/progesteron receptor (PR)-negative phenotype was identified. This result was confirmed by the analysis of G22P1/ku70, ATR and RAD51 mRNA levels on paired normal and tumor specimens from an extended breast cancer cohort (n = 75). RAD51 mRNA levels were inversely associated with PR status (p = 0.02) and the highest levels were, indeed, detected in ER-positive/PR-negative tumors (p = 0.03). RAD51 immunostaining of a tissue microarray confirmed the inverse relationship between high RAD51 expression and negative PR status (p = 0.002), as well as, the association with ER-positive/PR-negative phenotype (p = 0.003). Interestingly, the analysis of microarray expression data from 295 breast cancers indicate that RAD51 increased mRNA expression is associated with higher risk of tumor relapse, distant metastases and worst overall survival (p = 0.015, p = 0.009 and p = 0.013 respectively). Our results suggest that RAD51 expression determination could contribute to a better molecular classification of mammary tumors and may represent a novel tool for evaluating postoperative adjuvant therapy for breast cancer patients.

Original languageEnglish
Pages (from-to)536-545
Number of pages10
JournalInternational Journal of Cancer
Volume129
Issue number3
DOIs
Publication statusPublished - Aug 1 2011

Keywords

  • breast cancer
  • estrogen receptor
  • gene expression
  • progesterone receptor
  • RAD51

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'High RAD51 mRNA expression characterize estrogen receptor-positive/ progesteron receptor-negative breast cancer and is associated with patient's outcome'. Together they form a unique fingerprint.

Cite this